Skip to content

Effectiveness of smartphone-based mobile application on medication adherence in patients receiving growth hormone therapy-An exploratory observational study. (GTL-App)

Effectiveness of smartphone-based mobile application on medication adherence in patients receiving growth hormone therapy-An exploratory observational study. (GTL-App) - Effectiveness of smartphone-based mobile application on medication adherence in patients receiving growth hormone therapy-An exploratory observational study. (GTL-App)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000035997
Enrollment
50
Registered
2019-03-01
Start date
2019-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Short statue caused by -Growth hormone (GH) deficiency -Turner syndrome -Small for gestational age

Interventions

None listed

Sponsors

Department of Pediatrics, Nihon University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Never received growth hormone therapy before. -Aged 3 years or older. -Planning to: -Use GROWJECTOR-L. -Receive seven-days-a-week administration. -Use type A needles. -Written informed consent from a legally acceptable representative of the patient, along with informed assent if applicable.

Exclusion criteria

Exclusion criteria: -Contraindications for GH therapy. eg, Diabetes, malignancy, (possible) pregnancy. -Not supposed to be able to answer the questionnaire properly, eg, unable to read. -Judgement of physicians.

Design outcomes

Primary

MeasureTime frame
Medication adherence of patients during 24 weeks of observation period.

Secondary

MeasureTime frame
-Patients characteristics at registration. -Time course change in medication adherence. -Nonadherence-free survival. -Questionnaire on GH therapy. -Questionnaire on mobile application. -Factors affecting adherence to GH therapy. -Exploratory analysis of application log data.

Countries

Japan

Contacts

Public ContactTatsuhiko Urakami

Nihon University Hospital Department of Pediatrics

urakami.tatsuhiko@nihon-u.ac.jp81-3-3293-1711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026